1-8 of 8
Merrill Kies
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection

Xiuning Le, Frederico O. Gleber-Netto, M. Laura Rubin, Yun Qing, Robyn Du, Merrill Kies, George Blumenschein, Jr, Charles Lu, Faye M. Johnson, Diana Bell, Jeff Lewis, Jiexin Zhang, Lei Feng, Kaye Wilson, Kathrina Marcelo-Lewis, Jing Wang, Lawrence Ginsberg, Maura Gillison, J. Jack Lee, Funda Meric-Berstam, Gordon B. Mills, William N. William, Jr, Jeffrey N. Myers, Curtis R. Pickering
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (13): 2796–2806.
https://doi.org/10.1158/1078-0432.CCR-21-3239
Published: 01 July 2022
View article titled, Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection
Open the PDF for Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection in another window
Includes: Supplementary data
Journal Articles

Abstract 70: PARP1 as a potential therapeutic target in Merkel cell carcinoma

Renata Ferrarotto, Shirley Su, Lixia Diao, A Karina Eterovic, Victor Prieto, William Morrison, Jing Wang, Bonnie Glisson, Merrill Kies, Diana Bell
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (23_Supplement): 70.
https://doi.org/10.1158/1557-3265.AACRAHNS17-70
Published: 30 November 2017
View article titled, Abstract 70: PARP1 as a potential therapeutic target in Merkel cell carcinoma
Journal Articles

Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations

Yoshitsugu Mitani, Bin Liu, Pulivarthi H. Rao, Vishnupriya J. Borra, Mark Zafereo, Randal S. Weber, Merrill Kies, Guillermina Lozano, P. Andrew Futreal, Carlos Caulin, Adel K. El-Naggar
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (3): 725–733.
https://doi.org/10.1158/1078-0432.CCR-15-2867-T
Published: 31 January 2016
View article titled, Novel <em>MYBL1</em> Gene Rearrangements with Recurrent <em>MYBL1–NFIB</em> Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations
Open the PDF for Novel <em>MYBL1</em> Gene Rearrangements with Recurrent <em>MYBL1–NFIB</em> Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations in another window
Includes: Supplementary data
Journal Articles

Patients with Advanced Head and Neck Cancers Have Similar Progression-Free Survival on Phase I Trials and Their Last Food and Drug Administration–Approved Treatment

Ignacio Garrido-Laguna, Filip Janku, Gerald S. Falchook, Siqing Fu, David S. Hong, Aung Naing, Joanne Aaron, Xuemei Wang, Merrill Kies, Razelle Kurzrock
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (15): 4031–4037.
https://doi.org/10.1158/1078-0432.CCR-10-0672
Published: 28 July 2010
View article titled, Patients with Advanced Head and Neck Cancers Have Similar Progression-Free Survival on Phase I Trials and Their Last Food and Drug Administration–Approved Treatment
Open the PDF for Patients with Advanced Head and Neck Cancers Have Similar Progression-Free Survival on Phase I Trials and Their Last Food and Drug Administration–Approved Treatment in another window
Includes: Supplementary data
Journal Articles

Phase I Study of the Farnesyltransferase Inhibitor BMS-214662 Given Weekly in Patients with Solid Tumors

Vali Papadimitrakopoulou, Sofia Agelaki, Hai T. Tran, Merrill Kies, Robert Gagel, Ralph Zinner, Edward Kim, Gregory Ayers, John Wright, Fadlo Khuri
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (11): 4151–4159.
https://doi.org/10.1158/1078-0432.CCR-04-1659
Published: 01 June 2005
View article titled, Phase I Study of the Farnesyltransferase Inhibitor BMS-214662 Given Weekly in Patients with Solid Tumors
Open the PDF for Phase I Study of the Farnesyltransferase Inhibitor BMS-214662 Given Weekly in Patients with Solid Tumors in another window
Journal Articles

A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer

Zhongxing Liao, Ritsuko Komaki, Luka Milas, Chen Yuan, Merrill Kies, Joe Y. Chang, Melenda Jeter, Thomas Guerrero, George Blumenschien, Cheryl M. Smith, Frank Fossella, Barry Brown, James D. Cox
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3342–3348.
https://doi.org/10.1158/1078-0432.CCR-04-1741
Published: 02 May 2005
View article titled, A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer
Open the PDF for A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer in another window
Journal Articles

HER2 Expression in Salivary Gland Carcinomas: Dependence on Histological Subtype

Bonnie Glisson, A. Dimitrios Colevas, Robert Haddad, Jeoffrey Krane, Adel El-Naggar, Merrill Kies, Rosemary Costello, Carmen Summey, Matthew Arquette, Corey Langer, Philip C. Amrein, Marshall Posner
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (3): 944–946.
https://doi.org/10.1158/1078-0432.CCR-03-0253
Published: 10 February 2004
View article titled, HER2 Expression in Salivary Gland Carcinomas: <subtitle>Dependence on Histological Subtype</subtitle>
Open the PDF for HER2 Expression in Salivary Gland Carcinomas: <subtitle>Dependence on Histological Subtype</subtitle> in another window
Journal Articles

Phase I Study of Eniluracil, a Dihydropyrimidine Dehydrogenase Inactivator, and Oral 5-Fluorouracil with Radiation Therapy in Patients with Recurrent or Advanced Head and Neck Cancer

Rod A. Humerickhouse, M. Eileen Dolan, Daniel J. Haraf, Bruce Brockstein, Kerstin Stenson, Merrill Kies, Laura Sulzen, Mark J. Ratain, Everett E. Vokes
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (2): 291–298.
Published: 01 February 1999
View article titled, Phase I Study of Eniluracil, a Dihydropyrimidine Dehydrogenase Inactivator, and Oral 5-Fluorouracil with Radiation Therapy in Patients with Recurrent or Advanced Head and Neck Cancer
Open the PDF for Phase I Study of Eniluracil, a Dihydropyrimidine Dehydrogenase Inactivator, and Oral 5-Fluorouracil with Radiation Therapy in Patients with Recurrent or Advanced Head and Neck Cancer in another window